{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T05:07:05Z","timestamp":1693631225686},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T00:00:00Z","timestamp":1437177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00393-014-1547-0","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T16:04:00Z","timestamp":1437062640000},"page":"496-506","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myositiden"],"prefix":"10.1007","volume":"74","author":[{"given":"K.M.","family":"R\u00f6sler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,18]]},"reference":[{"key":"1547_CR1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2008.169375","volume":"80","author":"Amato","year":"2009","unstructured":"Amato AA, Barohn RJ (2009) Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry 80:1060\u20131068","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1547_CR2","doi-asserted-by":"crossref","unstructured":"Amato AA, Greenberg SA (2013) Inflammatory myopathies. Continuum (Minneap Minn) 19:1615\u20131633","DOI":"10.1212\/01.CON.0000440662.26427.bd"},{"key":"1547_CR3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00019052-200310000-00002","volume":"16","author":"Amato","year":"2003","unstructured":"Amato AA, Griggs RC (2003) Treatment of idiopathic inflammatory myopathies. Curr Opin Neurol 16:569\u2013575","journal-title":"Curr Opin Neurol"},{"key":"1547_CR4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","volume":"83","author":"Amato","year":"2014","unstructured":"Amato AA, Sivakumar K, Goyal N et al (2014) Treatment of sporadic inclusion body myositis with bimagrumab. Neurology 83:2239\u20132246","journal-title":"Neurology"},{"key":"1547_CR5","first-page":"438","volume":"35","author":"Andr\u00e1s","year":"2008","unstructured":"Andr\u00e1s C, Ponyi A, Constantin T et al (2008) Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35:438\u2013444","journal-title":"J Rheumatol"},{"key":"1547_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jmri.24613","volume":"41","author":"Azzabou","year":"2015","unstructured":"Azzabou N, Loureiro de Sousa P, Caldas E, Carlier PG (2015) Validation of a generic approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle. J Magn Reson Imaging 41:645\u2013653","journal-title":"J Magn Reson Imaging"},{"key":"1547_CR7","first-page":"569","volume":"15","author":"Baudin","year":"2012","unstructured":"Baudin PY, Azzabou N, Carlier PG, Paragios N (2012) Prior knowledge, random walks and human skeletal muscle segmentation. Med Image Comput Comput Assist Interv 15:569\u2013576","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"1547_CR8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nmd.2013.07.007","volume":"23","author":"De","year":"2013","unstructured":"De Bleecker JL, Lundberg IE, De Visser M (2013) 193rd ENMC International workshop pathology diagnosis of idiopathic inflammatory myopathies 30 November \u2013 2 December 2012, Naarden, The Netherlands. Neuromuscul Disord 23:945\u2013951","journal-title":"Neuromuscul Disord"},{"key":"1547_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1547_CR10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2013-305690","volume":"84","author":"Brady","year":"2013","unstructured":"Brady S, Squier W, Hilton-Jones D (2013) Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 84:1240\u20131246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1547_CR11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1212\/WNL.3.6.424","volume":"3","author":"Buchthal","year":"1953","unstructured":"Buchthal F, Pinelli P (1953) Muscle action potentials in polymyositis. Neurology 3:424\u2013436","journal-title":"Neurology"},{"key":"1547_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","volume":"24","author":"Bunch","year":"1981","unstructured":"Bunch TW (1981) Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24:45\u201348","journal-title":"Arthritis Rheum"},{"key":"1547_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","volume":"92","author":"Bunch","year":"1980","unstructured":"Bunch TW, Worthington JW, Combs JJ et al (1980) Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 92:365\u2013369","journal-title":"Ann Intern Med"},{"key":"1547_CR14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s10067-006-0526-5","volume":"26","author":"Caramaschi","year":"2007","unstructured":"Caramaschi P, Volpe A, Carletto A et al (2007) Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature. Clin Rheumatol 26:1795\u20131796","journal-title":"Clin Rheumatol"},{"key":"1547_CR15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nmd.2014.02.009","volume":"24","author":"Carlier","year":"2014","unstructured":"Carlier PG (2014) Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: Different methodology, different information and different implications. Neuromuscul Disord 24:390\u2013392","journal-title":"Neuromuscul Disord"},{"key":"1547_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"Chahin","year":"2008","unstructured":"Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70:418\u2013424","journal-title":"Neurology"},{"key":"1547_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","volume":"46","author":"Cherin","year":"2002","unstructured":"Cherin P, Pelletier S, Teixeira A et al (2002) Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: An open study with thirty-five adult patients. Arthritis Rheum 46:467\u2013474","journal-title":"Arthritis Rheum"},{"key":"1547_CR18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/rheumatology\/ker305","volume":"50","author":"Couderc","year":"2011","unstructured":"Couderc M, Gottenberg JE, Mariette X et al (2011) Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology 50:2283\u20132289","journal-title":"Rheumatology"},{"key":"1547_CR19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"1547_CR20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","volume":"132","author":"Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Schmidt J et al (2009) Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain 132:1536\u20131544","journal-title":"Brain"},{"key":"1547_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","volume":"98","author":"DeVere","year":"1975","unstructured":"DeVere R, Bradley WG (1975) Polymyositis: its presentation, morbidity and mortality. Brain 98:637\u2013666","journal-title":"Brain"},{"key":"1547_CR22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.11-0492","volume":"140","author":"Diot","year":"2011","unstructured":"Diot E, Carmier D, Marquette D et al (2011) IV immunoglobulin might be considered as a first-line treatment of severe interstitial lung disease associated with polymyositis. Chest 140:562\u2013563","journal-title":"Chest"},{"key":"1547_CR23","first-page":"103","volume":"30","author":"Dubourg","year":"2011","unstructured":"Dubourg O, Wanschitz J, Maisonobe T et al (2011) Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol 30:103\u2013108","journal-title":"Acta Myol"},{"key":"1547_CR24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/kep147","volume":"48","author":"Frikha","year":"2009","unstructured":"Frikha F, Rigolet A, Behin A et al (2009) Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases. Rheumatology 48:1166\u20131168","journal-title":"Rheumatology"},{"key":"1547_CR25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","volume":"157","author":"Gerami","year":"2007","unstructured":"Gerami P, Walling HW, Lewis J et al (2007) A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol 157:637\u2013644","journal-title":"Br J Dermatol"},{"key":"1547_CR26","first-page":"CD003643","volume":"8","author":"Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE, Choy EHS (2012) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev (4):CD003643 (PMID: 19821312). Cochrane Database Syst Rev 8:CD003643","journal-title":"Cochrane Database Syst Rev"},{"key":"1547_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","volume":"41","author":"Grable-Esposito","year":"2010","unstructured":"Grable-Esposito P, Katzberg HD, Greenberg SA et al (2010) Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 41:185\u2013190","journal-title":"Muscle Nerve"},{"key":"1547_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RMR.0b013e31825b2c35","volume":"22","author":"Del","year":"2011","unstructured":"Del Grande F, Carrino JA, Del Grande M et al (2011) Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging 22:39\u201343","journal-title":"Top Magn Reson Imaging"},{"key":"1547_CR29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S et al (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705\u2013713","journal-title":"Ann Neurol"},{"key":"1547_CR30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"Hayter","year":"2012","unstructured":"Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754\u2013765","journal-title":"Autoimmun Rev"},{"key":"1547_CR31","first-page":"692","volume":"16","author":"Hengstman","year":"2004","unstructured":"Hengstman GJD, Engelen BGM van, Venrooij WJ van (2004) Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 16:692\u2013699","journal-title":"Curr Opin Rheumatol"},{"key":"1547_CR32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mrm.22916","volume":"66","author":"Janiczek","year":"2011","unstructured":"Janiczek RL, Gambarota G, Sinclair CDJ et al (2011) Simultaneous T2 and lipid quantitation using IDEAL-CPMG. Magn Reson Med 66:1293\u20131302","journal-title":"Magn Reson Med"},{"key":"1547_CR33","first-page":"776","volume":"10","author":"Jordan","year":"2011","unstructured":"Jordan B, Hanisch F, Zierz S (2011) Myositiden. Nervenheilkunde 10:776\u2013786","journal-title":"Nervenheilkunde"},{"key":"1547_CR34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.237.14.1448","volume":"237","author":"Kagan","year":"1977","unstructured":"Kagan LJ (1977) Myoglobinemia in inflammatory myopathies. JAMA 237:1448\u20131452","journal-title":"JAMA"},{"key":"1547_CR35","first-page":"64","volume":"13","author":"Lambert","year":"1954","unstructured":"Lambert EH, Sayre GP, Eaton LM (1954) Electrical activity of muscle in polymyositis. Trans Am Neurol Assoc 13:64\u201369","journal-title":"Trans Am Neurol Assoc"},{"key":"1547_CR36","doi-asserted-by":"crossref","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","DOI":"10.1097\/00005792-199111000-00002"},{"key":"1547_CR37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713\u2013721","journal-title":"Arthritis Rheum"},{"key":"1547_CR38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"Res","author":"Marie","year":"2010","unstructured":"Marie I, Menard J-F, Hatron PY et al (2010) Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken) 62:1748\u20131755","journal-title":"Arthritis Care"},{"key":"1547_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-510X(74)90227-5","volume":"23","author":"Mechler","year":"1974","unstructured":"Mechler F (1974) Changing electromyographic findings during the chronic course of polymyositis. J Neurol Sci 23:237\u2013242","journal-title":"J Neurol Sci"},{"key":"1547_CR40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","volume":"25","author":"Mercuri","year":"2007","unstructured":"Mercuri E, Pichiecchio A, Allsop J et al (2007) Muscle MRI in inherited neuromuscular disorders: Past, present, and future. J Magn Reson Imaging 25:433\u2013440","journal-title":"J Magn Reson Imaging"},{"key":"1547_CR41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"Van","year":"2003","unstructured":"Van der Meulen MFG, Bronner IM, Hoogendijk JE et al (2003) Polymyositis: an overdiagnosed entity. Neurology 61:316\u2013321","journal-title":"Neurology"},{"key":"1547_CR42","first-page":"S53","volume":"199","author":"Miller","year":"2002","unstructured":"Miller J, Walsh Y, Saminaden S et al (2002) Randomised double-blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy. J Neurol Sci 199:S53","journal-title":"J Neurol Sci"},{"key":"1547_CR43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.23854","volume":"48","author":"Mohassel","year":"2013","unstructured":"Mohassel P, Mammen AL (2013) Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve 48:477\u2013483","journal-title":"Muscle Nerve"},{"key":"1547_CR44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","volume":"17","author":"Needham","year":"2007","unstructured":"Needham M, Fabian V, Knezevic W et al (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 17:194\u2013200","journal-title":"Neuromuscul Disord"},{"key":"1547_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0924-980X(94)00248-6","volume":"97","author":"Nirkko","year":"1995","unstructured":"Nirkko AC, R\u00f6sler KM, Hess CW (1995) Sensitivity and specificity of needle electromyography: a prospective study comparing automated interference pattern analysis with single motor unit potential analysis. Electroencephalogr Clin Neurophysiol 97:1\u201310","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1547_CR46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"1547_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0307-742X(21)00484-7","volume":"10","author":"Payan","year":"1984","unstructured":"Payan J (1984) Electromyography in polymyositis and some related disorders. Clin Rheum Dis 10:75\u201383","journal-title":"Clin Rheum Dis"},{"key":"1547_CR48","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","volume":"52","author":"Ramanan","year":"2005","unstructured":"Ramanan AV, Campbell-Webster N, Ota S et al (2005) The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 52:3570\u20133578","journal-title":"Arthritis Rheum"},{"key":"1547_CR49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(75)90115-X","volume":"26","author":"Riddoch","year":"1975","unstructured":"Riddoch D, Morgan-Hughes JA (1975) Prognosis in adult polymyositis. J Neurol Sci 26:71\u201380","journal-title":"J Neurol Sci"},{"key":"1547_CR50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"Rose","year":"2013","unstructured":"Rose MR (2013) 188th ENMC International Workshop: Inclusion Body Myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23:1044\u20131055","journal-title":"Neuromuscul Disord"},{"key":"1547_CR51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","volume":"66","author":"Rowin","year":"2006","unstructured":"Rowin J, Amato AA, Deisher N et al (2006) Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66:1245\u20131247","journal-title":"Neurology"},{"key":"1547_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0028-1090214","volume":"36","author":"Schmidt","year":"2009","unstructured":"Schmidt J (2009) Pathogenese der Einschlussk\u00f6rperchenmyositis: Stellenwert der Entz\u00fcndung und Bedeutung f\u00fcr Therapiestrategien. Aktuelle Neurol 36:121\u2013125","journal-title":"Aktuelle Neurol"},{"key":"1547_CR53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00115-010-2970-3","volume":"82","author":"Schmidt","year":"2011","unstructured":"Schmidt J, Vorgerd M (2011) Therapiestandard bei Myositiden und Muskeldystrophien. Nervenarzt 82:723\u2013732","journal-title":"Nervenarzt"},{"key":"1547_CR54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00393-009-0511-x","volume":"68","author":"Schoser","year":"2009","unstructured":"Schoser B (2009) Inflammatory myopathies. Z Rheumatol 68:665\u2013675 (quiz 676\u2013677)","journal-title":"Z Rheumatol"},{"key":"1547_CR55","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","volume":"48","author":"Sem","year":"2009","unstructured":"Sem M, Molber \u00d8, Lund MB, Gran JT (2009) Rituximab treatment of the anti-synthetase syndrome \u2013 a retrospective case series. Rheumatology 48:968\u2013971","journal-title":"Rheumatology"},{"key":"1547_CR56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","volume":"59","author":"Seshadri","year":"2008","unstructured":"Seshadri R, Feldman BM, Ilowite N et al (2008) The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum 59:989\u2013995","journal-title":"Arthritis Rheum"},{"key":"1547_CR57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.880020103","volume":"2","author":"Streib","year":"1979","unstructured":"Streib EW, Wilbourn AJ, Mitsumoto H (1979) Spontaneous electrical muscle fiber activity in polymyositis and dermatomyositis. Muscle Nerve 2:14\u201318","journal-title":"Muscle Nerve"},{"key":"1547_CR58","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.nmd.2012.05.010","volume":"22","author":"Thibaud","year":"2012","unstructured":"Thibaud J-L, Azzabou N, Barthelemy I et al (2012) Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR imaging of GRMD dogs. Neuromuscul Disord 22(Suppl 2):S85\u2013S99","journal-title":"Neuromuscul Disord"},{"key":"1547_CR59","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.revmed.2013.09.008","volume":"35","author":"Tournadre","year":"2014","unstructured":"Tournadre A (2014) Prise en charge th\u00e9rapeutique des polymyosites, dermatomyosites, myosites de chevauchement et myopathies n\u00e9crosantes auto-immunes. Rev Med Interne 35:466\u2013471","journal-title":"Rev Med Interne"},{"key":"1547_CR60","doi-asserted-by":"crossref","unstructured":"Troyanov Y, Targoff IN, Tremblay J-L et al (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84:231\u2013249","DOI":"10.1097\/01.md.0000173991.74008.b0"},{"key":"1547_CR61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000338474","volume":"68","author":"Uchino","year":"2012","unstructured":"Uchino M, Yamashita S, Uchino K et al (2012) Long-term outcome of polymyositis treated with high single-dose alternate-day prednisolone therapy. Eur Neurol 68:117\u2013121","journal-title":"Eur Neurol"},{"key":"1547_CR62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mus.880130315","volume":"13","author":"Uncini","year":"1990","unstructured":"Uncini A, Lange DJ, Lovelace RE et al (1990) Long-duration polyphasic motor unit potentials in myopathies: a quantitative study with pathological correlation. Muscle Nerve 13:263\u2013267","journal-title":"Muscle Nerve"},{"key":"1547_CR63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"Vencovsk\u00fd","year":"2000","unstructured":"Vencovsk\u00fd J, Jarosov\u00e1 K, Mach\u00e1cek S et al (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29:95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"1547_CR64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","volume":"41","author":"Villalba","year":"1998","unstructured":"Villalba L, Hicks JE, Adams EM et al (1998) Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41:392\u2013399","journal-title":"Arthritis Rheum"},{"key":"1547_CR65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"Van","year":"2010","unstructured":"Van de Vlekkert J, Hoogendijk JE, Haan RJ de et al (2010) Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord 20:382\u2013389","journal-title":"Neuromuscul Disord"},{"key":"1547_CR66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","volume":"51","author":"Vlekkert","year":"2015","unstructured":"Vlekkert J Van De, Maas M, Hoogendijk JE et al (2015) Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve 51:253\u2013258","journal-title":"Muscle Nerve"},{"key":"1547_CR67","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","volume":"64","author":"Werner","year":"2012","unstructured":"Werner JL, Christopher-Stine L, Ghazarian SR et al (2012) Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum 64:4087\u20134093","journal-title":"Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1547-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1547-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T06:02:08Z","timestamp":1652853728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1547-0"}},"subtitle":["Was ist der aktuelle Stand?"],"short-title":[],"issued":{"date-parts":[[2015,7,18]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1547"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1547-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,18]]}}}